Boehringer Ingelheim to Present Early Clinical Data on SIRPα Inhibitors at ASCO 2025

Boehringer Ingelheim will present data from two early-stage clinical trials investigating their SIRPα inhibitors, BI 765063 and BI 770371, at the 2025...
Home/KnloSights/Clinical Trial Updates/Boehringer Ingelheim to Present Early Clinical Data on SIRPα Inhibitors at ASCO 2025